942
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Prevalence and typology of potential drug interactions occurring in primary care patients

, , , , , & show all
Pages 92-99 | Received 13 Nov 2009, Accepted 26 Mar 2010, Published online: 27 May 2010

References

  • Sandars J, Esmail A. The frequency and nature of medical error in primary care: understanding the diversity across studies. Family Practice 2003;20:231–6.
  • Jacobson L, Elwyn G, Robling M, Tudor-Jones R. Error and safety in primary care: no clear boundaries. Family Practice 2003;20:237–41.
  • APEAS Study: estudio sobre la seguridad de los pacientes en Atención Primaria de Salud. Madrid: Spanish Ministry of Health and Consumer Affairs; 2008.
  • Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. Br Med J. 2000;320:774–7.
  • Kohn LT, Corrigan J, Donaldson MS. To err is human: building a safer health system. Washington DC: National Academies Press; 2000.
  • Moskowitz EJ, Nash DB. The quality and safety of ambulatory medical care: Current and future prospects. Am J Med Qual. 2007;22:274–88.
  • Woods DM, Thomas EJ, Holl JL, Weiss KB, Brennan TA. Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care 2007;16:127–31.
  • Recalde JM, Zunzunegui MV, Beland F. Interacciones entre medicamentos prescritos en la población mayor de 65 años. Aten Primaria 1998;22:434–9.
  • Vladislavona S, Reyes-Morales H, Torres-Arreola L, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7:147.
  • Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30:911–8.
  • Tulner L, Frankfort S, Gijsen G, Van Campen J, Koks C, Beinjnen J. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008;25:343–55.
  • Gagne JJ, Maio V, Ravinowitz C. Prevalence and predictor of potential drug-drug interactions in regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2008;33:141–51.
  • Perodeau GM, Poirier S, Foisy P, Ostoj M: Potential drugs interactions among the elderly in a home care program. J Geriatr Drug Therapy 1992;6:41–60.
  • American Society of Pharmacists Quality Assurance Indicators Development Group: Preliminary report of the ASHP QA indicators development group. Am J Hosp Pharm. 1991;48:1941–7.
  • Morales FJ, Ferrer JM, Palop V. Hipertensión arterial inducida por medicamentos. Hipertensión 1992;9:331–6.
  • Weideman RA, McKinney WP, Bernstein IH. Predictors of potential drug interactions. Hosp Pharm. 1998;33:835–40.
  • Coste J, Venot A. An epidemiologic approach to drug prescribing quality assessment: a study in primary care practice in France. Med Care 1999;37:1294–307.
  • Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y, . Discrepancies in the use of medications: their extent and predictors in an outpatient patient. Arch Intern Med. 2000;160:2129–34.
  • Bjerrun L, González B, Petersen G. Risk factor for potential drug interactions in general practice. Eur J Gen Pract. 2008;14:23–9.
  • Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Can Med Assoc J. 1996;154:1177–84.
  • Morera T, Gervasini G, Carrillo JA, Benitez J. Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting. Ann Pharmacother. 2004;38:1301–8.
  • Chen YF, Avery AJ, Neil KE, Johnson C, Dewey ME, Stockley IH. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Safety 2005;28:67–80.
  • Linnarsson R. Drug interactions in primary health care. Scand J Prim Health Care 1993;11:181–6.
  • Merlo J, Liedholm H, Lindblad U, Björck-Linné A, Fält J, Lindberg G, . Prescription with potential drug interactions dispensed at Swedish pharmacies in January 1999: Cross sectional study. Br Med J. 2001;323:427–8.
  • Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scan J Prim Health Care 2003;21:153–8.
  • Calvet A, Díez de Ulzurrun M, Pérez MT, Esteras J. Interacciones farmacológicas en tratamientos crónicos: Medidas correctoras para su prevención en un área básica de salud rural. Aten Primaria 2001;27:33–7.
  • General Council of the Spanish Official College of Pharmacists. Spanish Official College of Pharmacists medications database (BOT). Available from www.portalfarma.com/home.nsf. Accessed 8 January 2006.
  • López-Picazo JJ, Barragán A, Bravo G. Cartera de servicios de Atención Primaria 2003–2004 del Servicio Murciano de Salud. ed. Consejería de Sanidad de la Región de Murcia. Murcia, 2003.
  • Miettinen OS, Cook EF. Confounding: essence and detection. Am. J. Epidemiol. 1981;114:593–603.
  • Magro L, Conforti A, Del Zotti F, Leone R, Iorio ML, Meneghelli I, . Identification of severe potential drug-drug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol. 2008;64:303–9.
  • Borrel-Carrio F, Páez C, Suñol R, Orrego C, Gil N, Martí M. Errores clínicos y eventos adversos: Percepción de los médicos de atención primaria. Aten Primaria 2006;38:25–32.
  • Hansten PD, Horn JR. Drug interactions and updates quarterly. United States: Applied Therapeutics Inc.; 2002.
  • Caraballo MO, Rodriguez A, Palma CL, Nieto M, Desongles T, Santos B. Análisis comparativo de bases de datos de interacciones en función de indicadores de calidad estructural. Farm Aten Prim 2007;5:104.
  • Rodríguez-Terol A, Caraballo MO, Palma D. Calidad estructural de las bases de datos de interacciones. Farm Hosp. 2009;33:134–46.
  • Vitry A. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2006;63:709–14.
  • DRUGDEX® System [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically.
  • Stockley, Ivan. Stockley’s drug interactions, 7th. London: Pharmaceutical Press; 2005.
  • Lexi-Comp Online, Lexi-Interact™ Online, Hudson, Ohio: Lexi-Comp, Inc.; 2007; 29 January 2007. Lexi-Comp, Inc. Available from http://www.uptodate.com/crlsql/interact/frameset.jsp
  • Drugdigest™ Interactions [Internet database]. St Louis, MO: Express Scripts, Inc. Updated periodically. Available from http://www.drugdigest.org/wps/portal/ddigest
  • Drug Interactions Checker™ [Internet database]. Auckland, New Zealand: Drugsite Trust. Updated periodically. Available from http://www.drugs.com/drug_interactions.html
  • Brekke M, Rognstad S, Straand J, Furu K, Gjelstad S, Bjøner T, . Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Scand J Prim Health Care 2008;26:80–5.
  • Becker LB, Visser LE, Gelder T, Hofman A, Stricker BH. Interactions between 1992 and 2005 in people aged ≥55 year. Drugs Aging 2008;25:145–52.
  • Astrand E, Astrand B, Antonov K, Petersson G. Potential drug interaction during three-decade study period: a cross sectional study of a prescription register. Eur J Clin Pharmacol. 2007;63;851–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.